These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20600866)

  • 1. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
    Yuskaitis CJ; Beurel E; Jope RS
    Biochim Biophys Acta; 2010 Nov; 1802(11):1006-12. PubMed ID: 20600866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.
    Yuskaitis CJ; Mines MA; King MK; Sweatt JD; Miller CA; Jope RS
    Biochem Pharmacol; 2010 Feb; 79(4):632-46. PubMed ID: 19799873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.
    Mines MA; Yuskaitis CJ; King MK; Beurel E; Jope RS
    PLoS One; 2010 Mar; 5(3):e9706. PubMed ID: 20300527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel potent GSK3 inhibitor AF3581 reverts fragile X syndrome phenotype.
    Porceddu PF; Ciampoli M; Romeo E; Garrone B; Durando L; Milanese C; Di Giorgio FP; Reggiani A
    Hum Mol Genet; 2022 Mar; 31(6):839-849. PubMed ID: 34596681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental Emergence of Phenotypes in the Auditory Brainstem Nuclei of
    Rotschafer SE; Cramer KS
    eNeuro; 2017; 4(6):. PubMed ID: 29291238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent astrocyte activation in the fragile X mouse cerebellum.
    Pacey LK; Guan S; Tharmalingam S; Thomsen C; Hampson DR
    Brain Behav; 2015 Oct; 5(10):e00400. PubMed ID: 26516618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of Mitochondrial Components from Extracellular Vesicles Secreted from Astrocytes in a Mouse Model of Fragile X Syndrome.
    Ha BG; Heo JY; Jang YJ; Park TS; Choi JY; Jang WY; Jeong SJ
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated Purinergic Signalling in Fragile X Syndrome Cortical Astrocytes.
    Reynolds KE; Napier M; Fei F; Green K; Scott AL
    Neuromolecular Med; 2024 Sep; 26(1):36. PubMed ID: 39254908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome.
    Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y
    Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte-mediated disruption of ROS homeostasis in Fragile X mouse model.
    Vandenberg GG; Dawson NJ; Head A; Scott GR; Scott AL
    Neurochem Int; 2021 Jun; 146():105036. PubMed ID: 33785420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.
    Franklin AV; King MK; Palomo V; Martinez A; McMahon LL; Jope RS
    Biol Psychiatry; 2014 Feb; 75(3):198-206. PubMed ID: 24041505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
    Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
    Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
    Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
    Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome.
    Liu ZH; Huang T; Smith CB
    Neurobiol Dis; 2012 Mar; 45(3):1145-52. PubMed ID: 22227453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial bioenergetics of astrocytes in Fragile X syndrome: new perspectives on culture conditions and sex effects.
    Vandenberg GG; Thotakura A; Scott AL
    Am J Physiol Cell Physiol; 2022 Feb; 322(2):C125-C135. PubMed ID: 34817267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
    Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
    J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau reduction attenuates autism-like features in Fmr1 knockout mice.
    Zhao S; Jiang X; Han L; Jiang Y; Wang Y; Meng J; Zhu X; Zhang X; Luo H; Zhang YW
    Mol Autism; 2023 Nov; 14(1):42. PubMed ID: 37936174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.